Reducing Uncertainty in Value-Based Pricing Using Evidence Development Agreements: The Case of Continuous Intraduodenal Infusion of Levodopa/Carbidopa (Duodopa®) in Sweden

Author： Willis Michael  

Publisher： Adis International

ISSN： 1175-5652

Source： Applied Health Economics and Health Policy, Vol.8, Iss.6, 2010-11, pp. : 377-386

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A New Reimbursement System for Innovative Pharmaceuticals Combining Value-Based and Free Market Pricing

By Persson Ulf   Svensson Johanna  

Applied Health Economics and Health Policy, Vol. 10, Iss. 4, 2012-07 ,pp. : 217-225

Adis International

Access to resources Recommend Favorite

Short-Term Cost and Health Consequences of Duodenal Levodopa Infusion in Advanced Parkinson's Disease in Sweden: An Exploratory Study

By Kristiansen Ivar Sønbø   Bingefors Kerstin  

Applied Health Economics and Health Policy, Vol. 7, Iss. 3, 2009-09 ,pp. : 167-180

Adis International

Access to resources Recommend Favorite

Value-Based Insurance Design in Medicare

By Encinosa William E.  

Applied Health Economics and Health Policy, Vol. 7, Iss. 3, 2009-09 ,pp. : 149-154

Adis International

Access to resources Recommend Favorite

Depression Care for the Elderly Reducing Barriers to Evidence-Based Practice

By Ell Kathleen  

Home Health Care Services Quarterly, Vol. 25, Iss. 1-2, 2006-06 ,pp. : 115-148

Haworth Press

Access to resources Recommend Favorite

Moving Evidence-Based Interventions to Populations A Case Study Using Social Workers in Primary Care

By Geron Scott M.   Keefe Bronwyn  

Home Health Care Services Quarterly, Vol. 25, Iss. 1-2, 2006-06 ,pp. : 95-113

Haworth Press

Access to resources Recommend Favorite